RxDoctor Payments Data

Torey Collier, MD

Family Medicine · Houston, MSNPI 1700446358

Payments from drug & device makers

$1,348in general payments, 2019–2025

Across 72 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$339
  • Lilly USA, LLC$218
  • AstraZeneca$154
  • AbbVie$136
  • Phathom Pharmaceuticals, Inc.$88
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$88
  • plus $326 from 10 others

What the payments were for

  • Food & beverage$1,348100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,348 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$82,859
Medicare patients
221
Services billed
2,833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol94$101,044
MounjaroTirzepatide68$82,607
EliquisApixaban25$25,184
JardianceEmpagliflozin20$21,713
Repatha SureclickEvolocumab25$13,986
TrulicityDulaglutide12$10,977
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,544
Rosuvastatin Calcium136$2,671
Ezetimibe37$2,420
Albuterol Sulfate HfaAlbuterol Sulfate81$2,347
Gabapentin152$1,789
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen87$1,208
Duloxetine Hcl34$1,145
Diclofenac Sodium54$920
Colchicine16$884

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$154$101,04494 claims
Lilly USA, LLCMounjaro, Trulicity$218$93,58480 claims
PfizerEliquis$23$25,18425 claims
Boehringer IngelheimJardiance$40$21,71320 claims
GSKAnoro Ellipta$39$6,54414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Houston

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →